Bond Biosciences
ApprovedBond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract to treat or prevent disease.
Founded
2021
Focus
Small Molecules
About
Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract to treat or prevent disease.
Funding History
2Total raised: $2.8M
Seed$2.5MUndisclosedJun 15, 2022
Grant$299KNHLBIJul 15, 2021
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile